Clinical senates will have a formal role in authorising the new commissioning groups and will advise the NHS Commissioning Board on whether their plans are ‘clinically robust'.
Existing clinical networks will also be given a ‘stronger role' in commissioning, while local authority health and wellbeing boards will also have an input into CCG decisions.
But NHS Alliance chair Dr Michael Dixon said: ‘Senates should be only advisory not authorising and we must ensure that the full voice of primary care commissioners is represented within them.'
Pulse October survey
Take our April 2025 survey to potentially win £200 worth of tokens
